The aim of this study was to describe the epidemiology of chronic wounds in a large cohort of patients from a tertiary hospital out-patient clinic, and examine the significance of serum mannan-binding lectin for the occurrence and clinical presentation of such wounds. The study comprised 489 consecutive patients with chronic foot and leg ulcers. A clinical classification of wound-aetiology was performed, and mannan-binding lectin was measured in the sera of patients and healthy controls. The patients presented with 639 wounds altogether; diabetic foot ulcers (309), venous leg ulcers (188), arterial ulcers (109), and vasculitis (33). The mannan-binding lectin levels of patients with venous leg ulcer, alone or in combination with other types of wounds, differed significantly from the control group, and the frequency of values <100 ng/ml was significantly higher. In diabetic and arterial ulcer patients the frequency of values ≥3000 ng/ml was significantly higher than that of the control group. This suggests a role for the innate immunity in the pathology of venous leg ulcers, and indicates different roles for mannan-binding lectin in the development of ulcers with different aetiologies; it further suggests that mannan-binding lectin substitution should be tested in a controlled clinical trial. © 2009 The Authors.
CITATION STYLE
Bitsch, M., Laursen, I., Engel, A. M., Christiansen, M., Olesen Larsen, S., Iversen, L., … Karlsmark, T. (2009). Epidemiology of chronic wound patients and relation to serum levels of mannan-binding lectin. Acta Dermato-Venereologica, 89(6), 607–611. https://doi.org/10.2340/00015555-0730
Mendeley helps you to discover research relevant for your work.